Reverse Transcriptase News and Research

RSS
Janssen signs license agreement with PATH for early development HIV-1 medicine rilpivirine

Janssen signs license agreement with PATH for early development HIV-1 medicine rilpivirine

Study: More than 70% of bladder tumors display somatic mutations in TERT gene

Study: More than 70% of bladder tumors display somatic mutations in TERT gene

EGFR mutation testing dropped once funding from pharmaceutical industry discontinued

EGFR mutation testing dropped once funding from pharmaceutical industry discontinued

Inovio plans to advance synthetic hTERT cancer vaccine into clinical trials in 2014

Inovio plans to advance synthetic hTERT cancer vaccine into clinical trials in 2014

Theoretical mathematical models offer insights into therapeutic, prevention strategies for HIV

Theoretical mathematical models offer insights into therapeutic, prevention strategies for HIV

FDA approves sNDA for SUSTIVA for treatment of HIV-1 infected pediatric patients

FDA approves sNDA for SUSTIVA for treatment of HIV-1 infected pediatric patients

Synthetic anti-inflammatory substances related to marijuana may help fight HIV infection

Synthetic anti-inflammatory substances related to marijuana may help fight HIV infection

Patients with drug-resistant HIV can safely achieve viral suppression without NRTIs

Patients with drug-resistant HIV can safely achieve viral suppression without NRTIs

Gilead Sciences fourth quarter total revenues increase 18% to $2.59 billion

Gilead Sciences fourth quarter total revenues increase 18% to $2.59 billion

Cells lose ability to defend against transposons as they age

Cells lose ability to defend against transposons as they age

Researchers identify cancer-associated mutations

Researchers identify cancer-associated mutations

Gilead Sciences receives EC approval for Viread to treat HIV-1 infected children

Gilead Sciences receives EC approval for Viread to treat HIV-1 infected children

Study: 172K polymorphism makes certain forms of HIV less resistant to drugs

Study: 172K polymorphism makes certain forms of HIV less resistant to drugs

Novel integrase inhibitor dolutegravir shows promise for HIV-1 treatment

Novel integrase inhibitor dolutegravir shows promise for HIV-1 treatment

ART resistance increasing in sub-Saharan Africa

ART resistance increasing in sub-Saharan Africa

ARIAD Pharmaceuticals commences ponatinib Phase 3 trial in newly diagnosed CML

ARIAD Pharmaceuticals commences ponatinib Phase 3 trial in newly diagnosed CML

Merck signs two licensing agreements for investigational HIV drug candidates

Merck signs two licensing agreements for investigational HIV drug candidates

Merck, Chimerix sign license agreement for CMX157 to treat HIV infection

Merck, Chimerix sign license agreement for CMX157 to treat HIV infection

HIV drug resistance rates rising in some parts of Africa

HIV drug resistance rates rising in some parts of Africa

All adult patients with HIV should be offered ART: International Antiviral Society-USA panel

All adult patients with HIV should be offered ART: International Antiviral Society-USA panel